Key facts
- Notable investors include Zhongyiren Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhanqing Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhanqing Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhanqing Biotechnology
Provider of biological research services intended to support life science discovery and drug development. The company provides molecular and cellular analysis, quality control, sample analysis, pharmacological efficacy testing, and safety evaluation, enabling biopharmaceutical companies and research institutes to conduct comprehensive biological experiments and product assessments.
- Sector
- Business Products and Services (B2B)
- HQ
- Shanghai, China
- Founded
- 2018
- Employees
- 5
- Website
- biotranstech.com/
- Ownership
- Privately Held (backing)
Zhanqing Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhanqing Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhanqing Biotechnology in its N-PORT filings yet. We sweep new filings monthly.